Association of Ideal Cardiovascular Metrics and Serum High-Sensitivity C-Reactive Protein in Hypertensive Population

Increased levels of the inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) are associated with increased risk of cardiovascular disease. However, ideal cardiovascular health indicates lower risk of cardiovascular disease. This study aimed to investigate the effect of ideal cardiovascular health behaviors and health factors on hs-CRP levels among a hypertensive population. From 2006 to 2007, a cross-sectional study was conducted to survey 41,476 hypertensive subjects among the employees of Kailuan Corporation. Data from unified questionnaires and blood biochemical examinations were collected. The effects of ideal cardiovascular health behaviors and health factors on hs-CRP levels were evaluated through multivariate logistic regression analysis. A negative correlation was observed between hs-CRP levels and the number of ideal cardiovascular health metrics. The mean hs-CRP levels of subjects with zero to one, two, three, and four to six ideal cardiovascular health metrics were 1.11, 0.96, 0.90, and 0.80 mg/L, respectively (P<0.01). Multivariate logistic regression analysis revealed that after adjustment for sex, age, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and other risk factors, the risks for subjects with two, three, and four to six ideal health metrics with serum hs-CRP >3 mg/L were lower than those with zero to one ideal health metrics, with corresponding odd ratios of 0.86 (95%CI: 0.79–0.93, P<0.01), 0.76 (95%CI: 0.69–0.83, P<0.01), and 0.68 (95%CI: 0.64–0.75, P<0.01), respectively. This finding suggests that ideal cardiovascular health behaviors and health factors were related to decreased hs-CRP levels in a hypertensive population. Clinical Trial Registration Unique identifier: ChiCTR-TNC-11001489.

[1]  E. White,et al.  Lifestyle Factors and Inflammation: Associations by Body Mass Index , 2013, PloS one.

[2]  Hsing-Yi Chang,et al.  C-reactive protein predicts systolic blood pressure and pulse pressure but not diastolic blood pressure: the Cardiovascular Disease Risk Factors Two-Township Study. , 2013, American journal of hypertension.

[3]  Lawrence A Leiter,et al.  Inflammatory biomarkers CRP, MCP-1, serum amyloid alpha and interleukin-18 in patients with HTN and dyslipidemia: impact of diabetes mellitus on metabolic syndrome and the effect of statin therapy , 2013, Hypertension Research.

[4]  F. Soriguer,et al.  Factors determining high‐sensitivity C‐reactive protein values in the Spanish population. Di@bet.es study , 2013, European journal of clinical investigation.

[5]  A. Kadota,et al.  Does high-sensitivity C-reactive protein or low-density lipoprotein cholesterol show a stronger relationship with the cardio-ankle vascular index in healthy community dwellers?: the KOBE study. , 2012, Journal of atherosclerosis and thrombosis.

[6]  F. Paccaud,et al.  Association between Inflammatory and Obesity Markers in a Swiss Population-Based Sample (CoLaus Study) , 2012, Obesity Facts.

[7]  Kuibao Li,et al.  Prevalence of Ideal Cardiovascular Health and Its Relationship With the 4-Year Cardiovascular Events in a Northern Chinese Industrial City , 2012, Circulation. Cardiovascular quality and outcomes.

[8]  Chong Shen,et al.  Intra-individual variability of high-sensitivity C-reactive protein in Chinese general population. , 2012, International journal of cardiology.

[9]  X. Shu,et al.  Lifestyle determinants of C-reactive protein in middle-aged, urban Chinese men. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[10]  É. Dewailly,et al.  Population-based study of high plasma C-reactive protein concentrations among the Inuit of Nunavik , 2012, International journal of circumpolar health.

[11]  Mark A Pereira,et al.  Combined Lifestyle Factors and Cardiovascular Disease Mortality in Chinese Men and Women: The Singapore Chinese Health Study , 2011, Circulation.

[12]  V. Master,et al.  Review of the Relationship between C-Reactive Protein and Exercise , 2011, Molecular Diagnosis & Therapy.

[13]  W. Ling,et al.  Fruit consumption is associated with lower carotid intima-media thickness and C-reactive protein levels in patients with type 2 diabetes mellitus. , 2011, Journal of the American Dietetic Association.

[14]  W. Willett,et al.  The Dietary Approaches to Stop Hypertension eating plan affects C-reactive protein, coagulation abnormalities, and hepatic function tests among type 2 diabetic patients. , 2011, The Journal of nutrition.

[15]  X. Shu,et al.  Combined Impact of Lifestyle-Related Factors on Total and Cause-Specific Mortality among Chinese Women: Prospective Cohort Study , 2010, PLoS medicine.

[16]  S. Blair,et al.  The impact of combined health factors on cardiovascular disease mortality. , 2010, American heart journal.

[17]  A. Pandith,et al.  hs-CRP: A potential marker for hypertension in Kashmiri population , 2010, Indian Journal of Clinical Biochemistry.

[18]  Giske Ursin,et al.  Influence of individual and combined health behaviors on total and cause-specific mortality in men and women: the United Kingdom health and lifestyle survey. , 2010, Archives of internal medicine.

[19]  D. Mozaffarian,et al.  Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.

[20]  T. Wong,et al.  Association of C-reactive protein and metabolic syndrome in a rural Chinese population. , 2009, Clinical biochemistry.

[21]  J. Beilby,et al.  Prevalence and risk factor correlates of elevated C-reactive protein in an adult Australian population. , 2008, The American journal of cardiology.

[22]  Claude Lenfant,et al.  Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7): resetting the hypertension sails. , 2003, Hypertension.

[23]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[24]  Yu-ling,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[25]  Hanen Belfki,et al.  Relationship of C-reactive protein with components of the metabolic syndrome in a Tunisian population. , 2012, European journal of internal medicine.

[26]  D. Zdrenghea,et al.  Endothelial dysfunction in metabolic syndrome. , 2009, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[27]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.